Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven N Hart

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Breast Cancer Research and Treatment|August 23, 2015
Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapyMarissa S Ellingson, Steven N Hart, Krishna R Kalari, et al.
Journal of the National Cancer Institute|May 20, 2020
Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American WomenJulie R Palmer, Eric C Polley, Chunling Hu, et al.
NPJ Breast Cancer|July 13, 2024
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancerPeter A Fasching, Chunling Hu, Steven N Hart, et al.
Cancer Research|October 25, 2013
APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinomaBrandon Leonard, Steven N Hart, Michael B Burns, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2021
Mutations in <i>BRCA1/2</i> and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on PrognosisPeter A Fasching, Siddhartha Yadav, Chunling Hu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2023
Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in <i>ATM</i>, <i>BRCA1</i>, <i>BRCA2</i>, <i>CHEK2</i>, and <i>PALB2</i>Siddhartha Yadav, Nicholas J Boddicker, Jie Na, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancerFergus J Couch, Steven N Hart, Priyanka Sharma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2021
Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the BreastSiddhartha Yadav, Chunling Hu, Katherine L Nathanson, et al.
Breast Cancer Research : BCR|October 8, 2016
Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association ConsortiumTaru A Muranen, Carl Blomqvist, Thilo Dörk, et al.
Cancer Research|May 30, 2023
Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51CChunling Hu, Anil Belur Nagaraj, Hermela Shimelis, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Breast Cancer Research and Treatment|August 23, 2015
Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapyMarissa S Ellingson, Steven N Hart, Krishna R Kalari, et al.
Journal of the National Cancer Institute|May 20, 2020
Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American WomenJulie R Palmer, Eric C Polley, Chunling Hu, et al.
NPJ Breast Cancer|July 13, 2024
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancerPeter A Fasching, Chunling Hu, Steven N Hart, et al.
Cancer Research|October 25, 2013
APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinomaBrandon Leonard, Steven N Hart, Michael B Burns, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2021
Mutations in <i>BRCA1/2</i> and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on PrognosisPeter A Fasching, Siddhartha Yadav, Chunling Hu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2023
Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in <i>ATM</i>, <i>BRCA1</i>, <i>BRCA2</i>, <i>CHEK2</i>, and <i>PALB2</i>Siddhartha Yadav, Nicholas J Boddicker, Jie Na, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancerFergus J Couch, Steven N Hart, Priyanka Sharma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2021
Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the BreastSiddhartha Yadav, Chunling Hu, Katherine L Nathanson, et al.
Breast Cancer Research : BCR|October 8, 2016
Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association ConsortiumTaru A Muranen, Carl Blomqvist, Thilo Dörk, et al.
Cancer Research|May 30, 2023
Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51CChunling Hu, Anil Belur Nagaraj, Hermela Shimelis, et al.
Pageof 13